Developing Fixed-Combination Drug Products for Treatment of Hypertension. U.S. Food and Drug Administration. https://www.fda.gov/media/117975/download. Date Accessed August 6, 2026.
Codevelopment of Two or More New Investigational Drugs for Use in Combination. U.S. Food and Drug Administration. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/codevelopment-two-or-more-new-investigational-drugs-use-combination. Date Accessed August 6, 2026.
Treatment of Drug-Susceptible TB Using a 6-Month Regimen. World Health Organization. https://tbksp.who.int/en/node/2962. Date Accessed August 6, 2026.
Medication Adherence With Fixed-Dose Versus Free-Equivalent Combination Therapies: Systematic Review and Meta-Analysis. PubMed Central. https://pmc.ncbi.nlm.nih.gov/articles/PMC10074603/. Date Accessed August 6, 2026.
Highly Active Antiretroviral Therapy. StatPearls (NCBI Bookshelf). https://www.ncbi.nlm.nih.gov/books/NBK554533/. Date Accessed August 6, 2026.